Anti-angiogenic and anti-inflammatory effects of CD200–CD200R1 axis in oxygen-induced retinopathy mice model
- 146 Downloads
In this study, the expression changes and the potential effects of CD200 and its receptors during the process of retinal neovascularization (RNV) development had been detected, using a classic oxygen-induced retinopathy (OIR) mice model and CD200Fc (a CD200R1 agonist) intravitreal injection.
Materials and methods
7 day postnatal (P7) C57BL/6J mice were raised in hyperoxia incubators with 75±2% oxygen for 5 days, and returned to room air at P12. All animals were subdivided into three groups: normoxia control, OIR, and OIR+CD200Fc group. The mice of OIR+CD200Fc group were intravitreal injected with CD200Fc (2μg/μL, 0.5μL) at P12. Retinas and vitreous samples were harvested at P17. The expression and localization of CD200 and its receptors were analyzed by Western blot, quantitative real-time polymerase chain reaction (qRT-PCR), enzyme-linked immunosorbent assay (ELISA), and retinal whole-mount immunofluorescence. To investigate the effects of CD200Fc treatment, vascular endothelial growth factor (VEGF)-A, platelet-derived growth factor (PDGF)-BB, pro-inflammatory cytokines, NV area, and microglial activation were detected respectively.
In OIR group, both protein and RNA levels of CD200 and CD200R1 were significantly up-regulated. The increased CD200 and CD200R1 were co-localized with Alex594-labeled Griffonia simplicifolia isolectin B4 (IB4) on vascular endothelial cells in NV area of OIR samples, and CD200R1 was co-expressed with ionized calcium-bind adapter molecule 1 (iba1) on microglia in OIR samples at the same time. CD200Fc intravitreal injection could significantly reduce the release of VEGF-A, PDGF-BB, and pro-inflammatory cytokines; shrink the NV area; and inhibit the activation of microglia in OIR mice.
These findings suggested that the up-regulation of CD200 and CD200R1 was closely related to RNV development, and the antiangiogenic effects of CD200Fc in OIR model might be realized by inhibition of inflammatory response and microglia activation. The results may provide a new therapeutic target for RNV diseases.
KeywordsCD200–CD200R1 axis Retinal neovascularization Oxygen-induced retinopathy Inflammatory response Microglia
This work is supported by the National Natural Science Foundation of China (81600733) and the Institutional Science Foundation of the First Affiliated Hospital of Xi’an Jiaotong University (2017QN-02).
Compliance with ethical standards
Conflict of interest
The authors declare that there is no conflict of interest.
All animals involved in experiments were carried out in accordance with the US National Institute of Health (NIH) Guide for the Care and Use of Laboratory Animals published by the US National Academy of Sciences and approved by the Ethics Committee of Xi’an Jiaotong University.
- 8.Zarubina AV, Gal-Or O, Huisingh CE, Owsley C, Freund KB. Macular atrophy development and subretinal drusenoid deposits in anti-vascular endothelial growth factor treated age-related macular degeneration. Investig Ophthalmol Vis Sci. 2017;58(14):6038–45. https://doi.org/10.1167/iovs.17-22378.CrossRefGoogle Scholar
- 9.Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, Akesbi J, Nordmann JP. Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: cases requiring filtering surgery. J Fr Ophtalmol. 2018. https://doi.org/10.1016/j.jfo.2018.07.002.CrossRefGoogle Scholar
- 13.Hanhart J, Comaneshter DS, Freier-Dror Y, Vinker S. Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):651–63. https://doi.org/10.1007/s00417-018-3917-9.CrossRefGoogle Scholar
- 18.Rivera JC, Holm M, Austeng D, Morken TS, Zhou TE, Beaudry-Richard A, Sierra EM, Dammann O, Chemtob S. Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies. J Neuroinflammation. 2017;14(1):165. https://doi.org/10.1186/s12974-017-0943-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Barclay AN, Clark MJ, McCaughan GW. Neuronal/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure. Biochem Soc Symp. 1986;51:149–57.Google Scholar
- 20.Holmannova D, Kolackova M, Kondelkova K, Kunes P, Krejsek J, Andrys C. CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; part I: CD200/CD200R structure, activation, and function. Acta Medica (Hradec Kralove). 2012;55(1):12–7. https://doi.org/10.14712/18059694.2015.68.CrossRefGoogle Scholar
- 22.Hernangomez M, Klusakova I, Joukal M, Hradilova-Svizenska I, Guaza C, Dubovy P. CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model. J Neuroinflamm. 2016;13:43. https://doi.org/10.1186/s12974-016-0508-8.CrossRefGoogle Scholar
- 24.Varnum MM, Kiyota T, Ingraham KL, Ikezu S, Ikezu T. The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer’s disease. Neurobiol Aging. 2015;36(11):2995–3007. https://doi.org/10.1016/j.neurobiolaging.2015.07.027.CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Ren Y, Yang B, Yin Y, Leng X, Jiang Y, Zhang L, Li Y, Li X, Zhang F, He W, Zhang X, Cao X. Aberrant CD200/CD200R1 expression and its potential role in Th17 cell differentiation, chemotaxis and osteoclastogenesis in rheumatoid arthritis. Rheumatology (Oxford). 2015;54(4):712–21. https://doi.org/10.1093/rheumatology/keu362.CrossRefGoogle Scholar
- 26.Dick AD, Broderick C, Forrester JV, Wright GJ. Distribution of OX2 antigen and OX2 receptor within retina. Investig Ophthalmol Vis Sci. 2001;42(1):170–6.Google Scholar
- 28.Xu Y, Cheng Q, Yang B, Yu S, Xu F, Lu L, Liang X. Increased sCD200 levels in vitreous of patients with proliferative diabetic retinopathy and its correlation with VEGF and proinflammatory cytokines. Investig Ophthalmol Vis Sci. 2015;56(11):6565–72. https://doi.org/10.1167/iovs.15-16854.CrossRefGoogle Scholar
- 30.Huang R, Lan Q, Chen L, Zhong H, Cui L, Jiang L, Huang H, Li L, Zeng S, Li M, Zhao X, Xu F. CD200Fc attenuates retinal glial responses and RGCs apoptosis after optic nerve crush by modulating CD200/CD200R1 interaction. J Mol Neurosci. 2018;64(2):200–10. https://doi.org/10.1007/s12031-017-1020-z.CrossRefGoogle Scholar
- 32.Smith LE, Wesolowski E, McLellan A, Kostyk SK, D’Amato R, Sullivan R, D’Amore PA. Oxygen-induced retinopathy in the mouse. Investig Ophthalmol Vis Sci. 1994;35(1):101–11.Google Scholar
- 36.Gaiser MR, Weis CA, Gaiser T, Jiang H, Buder-Bakhaya K, Herpel E, Warth A, Xiao Y, Miao L, Brownell I. Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells. Oncoimmunology. 2018;7(5):e1426517. https://doi.org/10.1080/2162402x.2018.1426517.CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Horie S, Robbie SJ, Liu J, Wu WK, Ali RR, Bainbridge JW, Nicholson LB, Mochizuki M, Dick AD, Copland DA. CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization. Sci Rep. 2013;3:3072. https://doi.org/10.1038/srep03072.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Subhi Y, Krogh Nielsen M, Molbech CR, Oishi A, Singh A, Nissen MH, Sorensen TL. CD11b and CD200 on circulating monocytes differentiate two angiographic subtypes of polypoidal choroidal vasculopathy. Investig Ophthalmol Vis Sci. 2017;58(12):5242–50. https://doi.org/10.1167/iovs.17-22479.CrossRefGoogle Scholar
- 43.Oria M, Figueira RL, Scorletti F, Sbragia L, Owens K, Li Z, Pathak B, Corona MU, Marotta M, Encinas JL, Peiro JL. CD200–CD200R imbalance correlates with microglia and pro-inflammatory activation in rat spinal cords exposed to amniotic fluid in retinoic acid-induced spina bifida. Sci Rep. 2018;8(1):10638. https://doi.org/10.1038/s41598-018-28829-5.CrossRefPubMedPubMedCentralGoogle Scholar
- 46.Xu W, Wu Y, Hu Z, Sun L, Dou G, Zhang Z, Wang H, Guo C, Wang Y. Exosomes from microglia attenuate photoreceptor injury and neovascularization in an animal model of retinopathy of prematurity. Mol Ther Nucleic Acids. 2019;16:778–90. https://doi.org/10.1016/j.omtn.2019.04.029.CrossRefPubMedPubMedCentralGoogle Scholar